CMRX RSI Chart
Last 7 days
2.1%
Last 30 days
10%
Last 90 days
-13.9%
Trailing 12 Months
-11.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 25.4M | 17.1M | 8.7M | 324.0K |
2022 | 9.9M | 17.9M | 25.9M | 33.8M |
2021 | 5.6M | 4.6M | 3.1M | 2.0M |
2020 | 10.7M | 8.9M | 7.2M | 5.4M |
2019 | 8.8M | 9.0M | 10.6M | 11.6M |
2018 | 4.2M | 4.7M | 4.2M | 7.2M |
2017 | 5.6M | 4.4M | 4.6M | 4.5M |
2016 | 10.8M | 8.4M | 6.8M | 5.7M |
2015 | 4.5M | 7.7M | 8.8M | 10.8M |
2014 | 3.4M | 3.5M | 3.8M | 4.0M |
2013 | 32.4M | 27.0M | 7.1M | 4.4M |
2012 | 17.5M | 22.9M | 28.3M | 33.7M |
2011 | 0 | 0 | 0 | 12.1M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 14, 2024 | andriole michael t. | sold | -1,809 | 1.0375 | -1,744 | president and ceo |
Feb 14, 2024 | jakeman david | sold | -2,776 | 1.0439 | -2,660 | vp of finance and accounting |
Feb 14, 2024 | laspaluto michelle | sold | -2,022 | 1.0426 | -1,940 | chief financial officer |
Feb 01, 2024 | andriole michael t. | acquired | - | - | 83,750 | president and ceo |
Feb 01, 2024 | jakeman david | acquired | - | - | 10,750 | vp of finance and accounting |
Feb 01, 2024 | melemed allen s. | acquired | - | - | 28,125 | chief medical officer |
Feb 01, 2024 | laspaluto michelle | acquired | - | - | 25,000 | chief financial officer |
Feb 01, 2024 | alrutz michael albert | acquired | - | - | 21,875 | svp and general counsel |
Dec 29, 2023 | andriole michael t. | gifted | - | - | -17,000 | president and ceo |
Nov 17, 2023 | middleton fred a | bought | 16,521 | 0.9553 | 17,295 | - |
Which funds bought or sold CMRX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Tidal Investments LLC | new | - | 24,249 | 24,249 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -90.89 | -169,116 | 18,864 | -% |
May 15, 2024 | BARCLAYS PLC | reduced | -63.29 | -511,000 | 347,000 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -8.11 | 23,693 | 2,008,900 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -37.81 | -25,000 | 56,000 | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | added | 4.81 | 153,149 | 1,145,990 | 0.02% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | reduced | -1.7 | 93,749 | 1,229,050 | -% |
May 15, 2024 | ADAGE CAPITAL PARTNERS GP, L.L.C. | unchanged | - | 39,000 | 424,000 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | added | 334 | 41,182 | 52,058 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 0.31 | 109,573 | 1,156,390 | -% |
Unveiling Chimerix Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Chimerix Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.57 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Chimerix Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q4 | 2019Q3 | 2019Q2 |
Revenue | -100.0% | - | 4,000 | 15,000 | 26,000 | 420,000 | 814,000 | 32,555,000 | 21,718,667 | 10,882,333 | 46,000 | 107,000 | 391,000 | 1,435,000 | 1,120,000 | 1,609,000 | 1,402,000 | 1,241,000 | 1,480,000 | 1,719,000 | 1,958,000 | 1,438,000 |
Cost Of Revenue | - | - | - | - | - | - | - | 333,000 | - | 114,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | -100.0% | - | 4,000 | 11,000 | 26,000 | 283,000 | 814,000 | 32,222,000 | 440,000 | -99,000 | 46,000 | 107,000 | 391,000 | 1,435,000 | - | - | - | - | - | - | - | - |
Operating Expenses | 17.2% | 24,390,000 | 20,814,000 | 26,700,000 | 21,374,000 | 24,501,000 | 24,628,000 | 20,576,000 | 23,887,000 | 24,672,000 | 39,578,000 | 18,707,000 | 18,206,000 | 98,888,000 | 12,877,000 | 13,169,000 | 11,688,000 | 12,154,000 | 10,640,000 | - | 76,522,000 | 20,139,000 |
S&GA Expenses | -100.0% | - | 5,170,000 | 9,304,000 | 4,448,000 | 5,679,000 | 5,347,000 | 5,313,000 | 5,840,000 | 5,632,000 | 5,241,000 | 4,887,000 | 4,408,000 | 4,136,000 | 4,190,000 | 3,151,000 | 3,110,000 | 3,205,000 | 3,147,000 | - | 4,024,000 | 6,312,000 |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13,827,000 |
EBITDA Margin | -0.2% | 583 | 584 | 21.08 | 10.59 | 7.00 | 5.18 | -6.69 | -9.67 | -17.40 | -87.37 | -14.11 | -9.42 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -4.8% | 2,521,000 | 2,649,000 | 2,703,000 | 2,772,000 | 2,846,000 | 2,737,000 | 199,000 | -21,000 | 4,000 | 34,000 | 40,000 | 52,000 | 38,000 | 82,000 | 149,000 | 270,000 | 493,000 | 370,000 | - | 834,000 | 1,051,000 |
Income Taxes | - | - | - | - | - | - | -117,000 | 153,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 100.0% | - | -18,161,000 | -23,986,000 | - | - | -21,077,000 | 241,515,000 | - | - | - | -18,560,000 | - | - | - | - | - | - | - | - | - | - |
EBT Margin | 0% | 550 | 550 | 19.80 | 10.09 | 6.77 | 5.09 | -6.70 | -9.68 | -17.43 | -87.54 | -14.26 | -9.55 | - | - | - | - | - | - | - | - | - |
Net Income | -20.4% | -21,869,000 | -18,161,000 | -23,986,000 | -18,576,000 | -21,372,000 | -20,960,000 | 241,362,000 | -23,468,000 | -24,767,000 | -39,498,000 | -18,560,000 | -17,763,000 | -97,415,000 | -11,675,000 | -11,411,000 | -10,016,000 | -10,420,000 | -3,503,000 | - | -73,730,000 | -17,650,000 |
Net Income Margin | -0.6% | -254 | -253 | -9.76 | 10.57 | 6.90 | 5.09 | 5.94 | -5.94 | -10.12 | -87.54 | -47.63 | -30.35 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -20.3% | -17,545,000 | -14,588,000 | -17,948,000 | -14,354,000 | -22,287,000 | -19,987,000 | 7,056,000 | -10,560,000 | -23,447,000 | -34,037,000 | -15,293,000 | -12,836,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -8.8% | 194 | 213 | 225 | 241 | 259 | 279 | 294 | 54.00 | 66.00 | 101 | 133 | 147 | 159 | 85.00 | 94.00 | 102 | 108 | 119 | 128 | 163 | 178 |
Current Assets | -13.8% | 163 | 189 | 201 | 212 | 225 | 228 | 291 | 51.00 | 63.00 | 96.00 | 129 | 136 | 148 | 82.00 | 90.00 | 99.00 | 107 | 118 | 126 | 161 | 176 |
Cash Equivalents | -31.2% | 19.00 | 28.00 | 14.00 | 20.00 | 16.00 | 26.00 | 274 | 28.00 | 32.00 | 15.00 | 26.00 | 25.00 | 32.00 | 47.00 | 38.00 | 54.00 | 25.00 | 17.00 | 19.00 | 22.00 | 20.00 |
Inventory | - | - | - | - | - | - | - | - | 4.00 | 3.00 | 3.00 | 2.00 | - | - | - | - | - | - | - | - | - | - |
Net PPE | 17.4% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 1.0% | 20.00 | 20.00 | 17.00 | 17.00 | 18.00 | 22.00 | 20.00 | 26.00 | 18.00 | 32.00 | 29.00 | 28.00 | 25.00 | 11.00 | 10.00 | 9.00 | 7.00 | 9.00 | 16.00 | 14.00 | 14.00 |
Current Liabilities | 2.7% | 19.00 | 18.00 | 16.00 | 15.00 | 16.00 | 20.00 | 18.00 | 23.00 | 15.00 | 30.00 | 26.00 | 25.00 | 22.00 | 9.00 | 7.00 | 6.00 | 7.00 | 9.00 | 15.00 | 14.00 | 13.00 |
Shareholder's Equity | -9.8% | 174 | 193 | 208 | 224 | 240 | 257 | 274 | 28.00 | 48.00 | 68.00 | 105 | 119 | 134 | 73.00 | 83.00 | 93.00 | 101 | 110 | 112 | 149 | 164 |
Retained Earnings | -2.7% | -817 | -795 | -777 | -753 | -734 | -713 | -692 | -933 | -910 | -885 | -846 | -827 | -809 | -712 | -700 | -689 | -679 | -668 | -665 | -591 | -573 |
Additional Paid-In Capital | 0.3% | 992 | 988 | 986 | 978 | 975 | 971 | 966 | 962 | 958 | 954 | 951 | 947 | 943 | 786 | 784 | 782 | 780 | 779 | 777 | 741 | 738 |
Shares Outstanding | 0.8% | 90.00 | 89.00 | 89.00 | 89.00 | 89.00 | 88.00 | 87.00 | 87.00 | 87.00 | 85.00 | 86.00 | 86.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 94.00 | - | - | - | 111 | - | - | - | 579 | - | - | - | 136 | - | - | - | 137 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -20.1% | -17,518 | -14,588 | -17,933 | -14,342 | -22,225 | -19,988 | 7,128 | -10,560 | -23,447 | -34,023 | -15,288 | -12,723 | -37,896 | -9,045 | -8,299 | -7,874 | -10,820 | -3,469 | -42,161 | -13,817 | -15,734 |
Share Based Compensation | 22.0% | 2,749 | 2,253 | 7,880 | 2,961 | 4,363 | 4,165 | 3,819 | 3,593 | 3,708 | 3,133 | 3,431 | 3,112 | 2,584 | 1,568 | 1,283 | 1,391 | 1,326 | 1,559 | 1,529 | 2,367 | 4,073 |
Cashflow From Investing | -69.1% | 8,675 | 28,069 | 11,874 | 18,521 | 12,135 | -228,399 | 238,269 | 6,700 | 53,467 | 23,194 | 15,460 | 5,971 | -88,716 | 17,558 | -7,332 | 36,244 | 18,243 | 1,020 | 39,700 | 15,738 | -45,827 |
Cashflow From Financing | 235.5% | 208 | 62.00 | 78.00 | -31.00 | 199 | -32.00 | 778 | -11.00 | -13,460 | 52.00 | 557 | 117 | 111,703 | 346 | 260 | 578 | 229 | 1.00 | 166 | 18.00 | 160 |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Total revenues | $ 0 | $ 283 |
Operating expenses: | ||
Research and development | 18,844 | 18,822 |
General and administrative | 5,546 | 5,679 |
Total operating expenses | 24,390 | 24,501 |
Loss from operations | (24,390) | (24,218) |
Other income: | ||
Interest income and other, net | 2,521 | 2,846 |
Net loss | (21,869) | (21,372) |
Other comprehensive (loss) income: | ||
Unrealized (loss) gain on debt investments, net | (185) | 106 |
Comprehensive loss | $ (22,054) | $ (21,266) |
Per share information: | ||
Net loss, basic (in dollars per share) | $ (0.25) | $ (0.24) |
Net loss, diluted (in dollars per share) | $ (0.25) | $ (0.24) |
Weighted-average shares outstanding, basic (in shares) | 89,259,106 | 88,294,624 |
Weighted-average shares outstanding, diluted (in shares) | 89,259,106 | 88,294,624 |
Contract and grant revenue | ||
Total revenues | $ 0 | $ 234 |
Licensing revenue | ||
Total revenues | $ 0 | $ 49 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 19,026 | $ 27,661 |
Short-term investments, available-for-sale | 140,002 | 155,174 |
Accounts receivable | 1 | 4 |
Prepaid expenses and other current assets | 4,003 | 6,271 |
Total current assets | 163,032 | 189,110 |
Long-term investments | 29,133 | 21,657 |
Property and equipment, net of accumulated depreciation | 263 | 224 |
Operating lease right-of-use assets | 1,354 | 1,482 |
Other long-term assets | 260 | 301 |
Total assets | 194,042 | 212,774 |
Current liabilities: | ||
Accounts payable | 3,823 | 2,851 |
Accrued liabilities | 15,112 | 15,592 |
Total current liabilities | 18,935 | 18,443 |
Line of credit commitment fee | 0 | 125 |
Lease-related obligations | 1,005 | 1,177 |
Total liabilities | 19,940 | 19,745 |
Stockholders’ equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.001 par value, 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 89,629,902 and 88,929,300 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 90 | 89 |
Additional paid-in capital | 991,583 | 988,457 |
Accumulated other comprehensive (gain) loss, net | (178) | 7 |
Accumulated deficit | (817,393) | (795,524) |
Total stockholders’ equity | 174,102 | 193,029 |
Total liabilities and stockholders’ equity | $ 194,042 | $ 212,774 |